H.R. 7188 · 118th Congress · House

Shandra Eisenga Human Cell and Tissue Product Safety Act

In Congress· Received in the Senate.
Introduced
Feb 1, 24
Passed House
Dec 16, 24
Passed Senate
Pending
Sent to President
Pending
Signed into Law
Pending

Executive Summary

Shandra Eisenga Human Cell and Tissue Product Safety Act

This bill requires federal agencies to update guidance, regulations, and educational materials about transplants involving human cell and tissue products, particularly with respect to safety and eligibility standards.

Specifically, the Department of Health and Human Services must support the development of educational materials for health care providers about issues relating to organ, tissue, and eye donations; screening tests; and other aspects of donations. The Food and Drug Administration (FDA) must review current guidance on donor eligibility and, if appropriate, update it with information on how to reduce the spread of tuberculosis or sepsis in association with donations. The FDA must also publish information about its Tissue Reference Group and data about FDA inspections and registrations of human cell and tissue establishments.

The bill also establishes specific civil penalties for violations of regulations governing procedures for human cell and tissue products. The FDA must consider and recommend ways to update these regulations after a public comment period.

Previous Versions

00Feb 1, 2024

Shandra Eisenga Human Cell and Tissue Product Safety Act

This bill requires the Department of Health and Human Services (HHS) to educate the public and health care providers about the benefits and risks of transplants that use human cell or tissue products, including the risk of infections.

HHS must develop the educational campaign after taking into consideration information about products that carry the highest risk of transmitting infections to transplant recipients. HHS may award grants to other entities to conduct public awareness initiatives and media campaigns about the risk of infections. 

The bill also establishes specific civil penalties for violations of laws regarding the spread of communicable diseases and regulations regarding procedures for human cell or tissue products.

Action Timeline

18
  1. DEC 17, 2024IntroReferral

    Received in the Senate.

  2. DEC 16, 2024Floor

    Mr

    Bucshon moved to suspend the rules and pass the bill, as amended.

  3. DEC 16, 2024Floor

    Considered under suspension of the rules

    (consideration: CR H7167-7170)

    7167Yea
    7170Nay
    0NV
  4. DEC 16, 2024Floor

    DEBATE - The House proceeded with forty minutes of debate on H.R. 7188.

  5. DEC 16, 2024Floor

    Passed/agreed to in House

    On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H7167-7168)

    7167Yea
    7168Nay
    0NV
  6. DEC 16, 2024Floor

    On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H7167-7168)

    7167Yea
    7168Nay
    0NV
  7. DEC 16, 2024Floor

    Motion to reconsider laid on the table Agreed to without objection.

  8. NOV 22, 2024Committee

    Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 118-766.

    118Yea
    766Nay
    0NV
  9. NOV 22, 2024Committee

    Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 118-766.

    118Yea
    766Nay
    0NV
  10. NOV 22, 2024Calendars

    Placed on the Union Calendar, Calendar No. 632.

  11. SEP 18, 2024Committee

    Committee Consideration and Mark-up Session Held

  12. SEP 18, 2024Committee

    Ordered to be Reported (Amended) by the Yeas and Nays: 40 - 0.

    40Yea
    0Nay
    0NV
  13. MAY 16, 2024Committee

    Subcommittee Consideration and Mark-up Session Held

  14. MAY 16, 2024Committee

    Forwarded by Subcommittee to Full Committee (Amended) by the Yeas and Nays: 27 - 0.

    27Yea
    0Nay
    0NV
  15. FEB 02, 2024Committee

    Referred to the Subcommittee on Health.

  16. FEB 01, 2024IntroReferral

    Introduced in House

  17. FEB 01, 2024IntroReferral

    Introduced in House

  18. FEB 01, 2024IntroReferral

    Referred to the House Committee on Energy and Commerce.

Committees

6

Energy and Commerce Committee

hsif00

Referred: Nov 22, 2024

Active

Energy and Commerce Committee

hsif00

Referred: Sep 18, 2024

Active

Health Subcommittee

hsif14

Referred: May 16, 2024

Active

Health Subcommittee

hsif14

Referred: May 16, 2024

Active

Health Subcommittee

hsif14

Referred: Feb 2, 2024

Active

Energy and Commerce Committee

hsif00

Referred: Feb 1, 2024

Active